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EC
Endothelial cell MEC Microvascular endothelial cell MSC Mesenchymal stromal cell TGF-β Transforming growth factor-β To the Editor: We read with interest the recent report by Favaro et al [1] suggesting that microvascular endothelial cells (MECs) isolated from human islets of Langerhans could be protected from hyperglycaemia-induced apoptosis by gastrointestinal peptides. In this study, as in several previous studies [2] [3] [4] [5] , the MECs were expanded in vitro from a population that had been isolated from dispersed human islet cells using anti-CD105 immunobeads. CD105 (also known as endoglin) is a membrane glycoprotein that acts with transforming growth factor (TGF)-β receptors as an auxiliary binding protein for members of the TGF-β family, including activin, TGF-β1/β3 and bone morphogenic proteins. Macro-and microvascular endothelial cells (ECs) are certainly CD105-positive, but this accessory receptor is also highly expressed by a range of other cell types including bone marrow-and tissue-derived mesenchymal stromal cell (MSC)-like populations. In accordance with this, we have recently isolated from human islets, and expanded in vitro, a population of CD105-expressing cells that are clearly not MECs, but which share phenotypic characteristics with other cells that have been immuno-isolated on the basis of CD105 expression and identified as islet MECs for in vitro studies [1] [2] [3] [4] [5] .
Our cell population was isolated and expanded essentially as described for MSCs [6] . Briefly, human islets (obtained from the King's College London Human Islet Isolation Unit, with appropriate ethics approval) were dissociated by incubation in 0.02% (wt/vol.) EDTA solution with trituration. Cells were resuspended in Dulbecco's Modified Eagle's Medium supplemented with L-glutamine (2 mM), penicillin (100 U/ml), streptomycin (172 μmol/l) and FCS (10% vol./ vol.), seeded in six-well tissue culture dishes and incubated at 37°C in a humidified atmosphere containing 5%/95% CO 2 /air. The medium was changed after 24 h, with removal of non-adherent cells, and when adherent cultures reached confluence, they were trypsinised and subcultured into tissue culture flasks. These cells are likely to be a heterogeneous population of adherent islet stromal cells, including fibroblasts, myofibroblasts and pericytes, as well as MSCs with differentiation potential. In accordance with this, the cells possessed many of the attributes associated with MSCs [6, 7] , rather than MECs, as shown in Fig. 1 . They did not exhibit the typical cobble-stone morphology of monolayermorphology similar to MSCs (Fig. 1d) . Cells within this population were multipotent and differentiated in vitro along adipogenic (Fig. 1f), osteogenic (Fig. 1g) and chondrogenic (Fig. 1h) lineages, assessed by positive oil red O, alizarin red and alcian blue staining, respectively. Flow cytometry demonstrated that they expressed cell surface antigens typically associated with MSCs, including CD105, CD13, CD44, CD73 and CD90, but did not express cell surface antigens characteristic of MECs, including CD31, CD34, CD69, CD117 and vascular endothelial growth factor receptor-2 [7] . Our cells were capable of expansion in standard EC culture medium supplemented with EC growth factors and, in common with both macro-and microvascular ECs [8] , they formed capillary-like tubes when maintained on Matrigel (BD Biosciences, Oxford, UK; not shown), as has been reported previously for cell populations isolated from human islets on the basis of CD105 expression [2] . Despite this, the morphology, cell surface marker/receptor expression and multipotency of our cell isolates are not consistent with an islet MEC phenotype.
It is well documented that CD105 is not an EC-specific marker in other tissues, and we here extend this to human islets of Langerhans. Our demonstration that human islets contain more than one population of CD105-expressing cells suggests that isolation strategies based solely on CD105 expression are unlikely to generate a purified islet MEC population. The initial immuno-isolated population will contain MECs because they express CD105, but during expansion in culture the MECs may be outgrown by a CD105-expressing MSC population. The precise identity of the CD105-positive, non-MEC population that we have isolated and expanded from human islets is uncertain, but our observations suggest that cells isolated and characterised solely on the basis of CD105 expression (or of the expression of CD146, another general stromal cell marker) are likely to comprise a heterogeneous population that may be unsuitable for functional studies of islet MECs. Contribution statement CPDW-J and PMJ were responsible for the conception of the letter. CEC, CEF, PD, NN and PC generated and analysed data. All authors contributed to the drafting and revision of the letter, and approved the final version.
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